Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling
The G protein-coupled receptor proteinase-activated receptor 2 (PAR2) has been implicated in various aspects of cellular physiology including inflammation, obesity and cancer. In cancer, it usually acts as a driver of cancer progression in various tumor types by promoting invasion and metastasis in...
Main Authors: | Hendrik Ungefroren, David Witte, Bernhard H. Rauch, Utz Settmacher, Hendrik Lehnert, Frank Gieseler, Roland Kaufmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/11/2494 |
Similar Items
-
Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer
by: Hendrik Ungefroren, et al.
Published: (2018-05-01) -
Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer
by: David Witte, et al.
Published: (2016-11-01) -
RAC1B Suppresses TGF-β-Dependent Chemokinesis and Growth Inhibition through an Autoregulatory Feed-Forward Loop Involving PAR2 and ALK5
by: Hannah Otterbein, et al.
Published: (2019-08-01) -
The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility
by: Hendrik Ungefroren, et al.
Published: (2017-12-01) -
RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
by: Hendrik Ungefroren, et al.
Published: (2019-05-01)